PA
ZGN icon

PharVision Advisers’s Zegna ZGN Stock Holding History

PharVision Advisers’s Portfolio ZGN Stock Details ZGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$132K Buy
+12,690
New +$131K 1.34% 21
2025
Q4 		– Sell
-14,987
Closed -$142K – 1045
2025
Q3 		$142K Buy
+14,987
New +$130K 0.08% 578
2025
Q2 		– Sell
-18,254
Closed -$135K – 452
2025
Q1 		$135K Buy
+18,254
New +$151K 0.19% 233

Other funds holding ZGN

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $32B AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PharVision Advisers's ZGN Position: Q1 2026 in Review

PharVision Advisers opened a new position in Zegna (ZGN) in Q1 2026: 12,690 shares worth $132K. The stake represents 1.34% of the portfolio and ranks #21 among its holdings. This is a return to the name: PharVision Advisers previously reported a position in ZGN as recently as Q3 2025.

PharVision Advisers first reported a position in ZGN in Q1 2025 and has held it in 3 quarters since. The position peaked at $142K in Q3 2025. 124 funds tracked by Wall St. Rank hold ZGN as of Q1 2026.

  • PharVision Advisers held 12,690 shares of Zegna worth $132K as of Q1 2026.
  • Zegna was a new PharVision Advisers position in Q1 2026.
  • Zegna made up 1.34% of PharVision Advisers's portfolio in Q1 2026, its #21 holding.
  • PharVision Advisers first reported a position in Zegna in Q1 2025 and has held it in 3 quarters since.
  • PharVision Advisers's Zegna position peaked at $142K in Q3 2025.
  • 124 funds tracked by Wall St. Rank held Zegna as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.